Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager
Moberg Pharma AB (publ) Logo
Moberg Pharma AB (publ)
STO:MOB
Watchlist
Price: 12 SEK -5.29%
Market Cap: 560.3m SEK
Have any thoughts about
Moberg Pharma AB (publ)?
Write Note

Moberg Pharma AB (publ)
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Moberg Pharma AB (publ)
Cash from Financing Activities Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
I
FLERIE

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Moberg Pharma AB (publ)
STO:MOB
Cash from Financing Activities
kr92.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Cash from Financing Activities
kr196.1m
CAGR 3-Years
N/A
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Cash from Financing Activities
kr1.3B
CAGR 3-Years
45%
CAGR 5-Years
22%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Cash from Financing Activities
-kr298.5m
CAGR 3-Years
N/A
CAGR 5-Years
-99%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Cash from Financing Activities
kr23.7m
CAGR 3-Years
-55%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Cash from Financing Activities
kr572.3m
CAGR 3-Years
6%
CAGR 5-Years
74%
CAGR 10-Years
N/A

See Also

What is Moberg Pharma AB (publ)'s Cash from Financing Activities?
Cash from Financing Activities
92.3m SEK

Based on the financial report for Dec 31, 2023, Moberg Pharma AB (publ)'s Cash from Financing Activities amounts to 92.3m SEK.

What is Moberg Pharma AB (publ)'s Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-14%

Over the last year, the Cash from Financing Activities growth was -14%.

Back to Top